Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$1.2 billion.

  • Ocular Therapeutix's Retained Earnings fell 2984.44% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.2 billion, marking a year-over-year decrease of 2984.44%. This contributed to the annual value of -$1.2 billion for FY2025, which is 2984.44% down from last year.
  • Ocular Therapeutix's Retained Earnings amounted to -$1.2 billion in Q4 2025, which was down 2984.44% from -$1.1 billion recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Retained Earnings peaked at -$536.1 million during Q1 2021, and registered a low of -$1.2 billion during Q4 2025.
  • Over the past 5 years, Ocular Therapeutix's median Retained Earnings value was -$668.1 million (recorded in 2023), while the average stood at -$736.6 million.
  • Examining YoY changes over the last 5 years, Ocular Therapeutix's Retained Earnings showed a top increase of 121.52% in 2021 and a maximum decrease of 3233.63% in 2021.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Retained Earnings stood at -$545.8 million in 2021, then fell by 13.02% to -$616.8 million in 2022, then decreased by 13.09% to -$697.6 million in 2023, then dropped by 27.74% to -$891.1 million in 2024, then dropped by 29.84% to -$1.2 billion in 2025.
  • Its Retained Earnings stands at -$1.2 billion for Q4 2025, versus -$1.1 billion for Q3 2025 and -$1.0 billion for Q2 2025.